KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.05 $8.45 Friday, 26th Apr 2024 ABEO stock ended at $3.26. This is 2.19% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.62% from a day low at $3.20 to a day high of $3.38.
90 days $3.05 $9.01
52 weeks $2.85 $9.01

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Mar 14, 2013 $0.550 $0.580 $0.550 $0.560 25 000
Mar 13, 2013 $0.520 $0.580 $0.520 $0.580 20 000
Mar 12, 2013 $0.500 $0.600 $0.500 $0.600 35 000
Mar 11, 2013 $0.490 $0.540 $0.490 $0.520 5 000
Mar 08, 2013 $0.460 $0.490 $0.460 $0.460 15 000
Mar 07, 2013 $0.450 $0.490 $0.450 $0.490 20 000
Mar 06, 2013 $0.490 $0.490 $0.450 $0.450 0
Mar 05, 2013 $0.470 $0.490 $0.470 $0.490 5 000
Mar 04, 2013 $0.490 $0.490 $0.490 $0.490 0
Mar 01, 2013 $0.490 $0.490 $0.490 $0.490 0
Feb 28, 2013 $0.490 $0.490 $0.490 $0.490 5 000
Feb 27, 2013 $0.500 $0.510 $0.500 $0.500 25 000
Feb 26, 2013 $0.450 $0.450 $0.450 $0.450 5 000
Feb 25, 2013 $0.430 $0.500 $0.430 $0.500 5 000
Feb 22, 2013 $0.470 $0.490 $0.450 $0.490 20 000
Feb 21, 2013 $0.490 $0.490 $0.490 $0.490 5 000
Feb 20, 2013 $0.500 $0.500 $0.450 $0.500 0
Feb 19, 2013 $0.450 $0.500 $0.450 $0.500 5 000
Feb 15, 2013 $0.550 $0.550 $0.410 $0.490 90 000
Feb 14, 2013 $0.550 $0.560 $0.510 $0.550 25 000
Feb 13, 2013 $0.450 $0.550 $0.450 $0.550 15 000
Feb 12, 2013 $0.450 $0.510 $0.450 $0.510 0
Feb 11, 2013 $0.500 $0.510 $0.470 $0.500 20 000
Feb 08, 2013 $0.500 $0.500 $0.470 $0.500 35 000
Feb 07, 2013 $0.490 $0.510 $0.420 $0.510 10 000
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT